Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

ARHGAP22 Activators

ARHGAP22, also known as Rho GTPase activating protein 22, is a member of the RhoGAP family of proteins, which are known to regulate the Rho family of small GTPases. Rho GTPases are critical for various cellular processes, including cell polarization, migration, and adhesion, as well as cytoskeletal dynamics. The protein is encoded in humans by the ARHGAP22 gene.As a Rho GTPase activating protein (RhoGAP), ARHGAP22 negatively regulates Rho GTPases by promoting their inactive GDP-bound state. This regulation plays a crucial role in controlling actin cytoskeleton reorganization and various cellular functions.

ARHGAP22 specifically contains a RhoGAP domain, which is responsible for its GAP activity. It also has a BAR domain, which is believed to sense or induce membrane curvature and may be involved in vesicle trafficking.Dysregulation or mutation of ARHGAP22, like other RhoGAP proteins, may contribute to disease states, including cancer, by disrupting the balance of Rho GTPase activity. However, more research is needed to elucidate the specific roles of ARHGAP22 in health and disease.As a regulator of crucial cellular functions, ARHGAP22 represents an interesting target for further research, which could lead to potential interventions for diseases associated with aberrant Rho GTPase activi

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632, a Rho kinase inhibitor, could indirectly affect ARHGAP22's function in cell migration and cytoskeleton organization.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib, a Src family kinase inhibitor, might indirectly influence ARHGAP22 activity in signaling pathways.

PP 1

172889-26-8sc-203212
sc-203212A
1 mg
5 mg
$86.00
$145.00
6
(1)

PP2, as a Src family kinase inhibitor, could indirectly affect ARHGAP22's role in cellular processes like migration.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, might influence ARHGAP22 indirectly by altering PI3K-Akt signaling pathways.